Valeant Pharmaceuticals Announces Launch Of $850M Private Offering Of Senior Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announced today that it has launched an offering of approximately $850 million aggregate principal amount of senior unsecured notes (the "Notes"). The net proceeds of the offering is expected to be used to finance the redemption of all of the